PREVALENCE OF DYSLIPIDEMIA AND HYPERURICEMIA IN ADULTS UNDERGOING REGULAR HEALTH CHECK-UPS AT MILITARY HOSPITAL 103

Thi Minh Hoang1, , Ba Tung Nguyen2, Quang Thuan Huynh1, Thi Hang Ho1
1 Bộ môn - Khoa Sinh hóa, Bệnh viện Quân y 103, Học viện Quân y
2 Học viện Quân y

Main Article Content

Abstract

Objectives: To determine the rate of dyslipidemia, hyperuricemia, and the relationship between these two disorders in adults undergoing regular health check-ups. Methods: A cross-sectional descriptive study was conducted on 4,251 adults who underwent regular health examinations at Military Hospital 103 between March and July 2025. Dyslipidemia was defined according to National Cholesterol Education Program - Adult Treatment Panel III (NCEP ATP III) criteria; hyperuricemia was defined as serum uric acid > 420 µmol/L in males and  > 360 µmol/L in females after 8 - 12 hours of fasting. Results: The prevalence of dyslipidemia was 77.9%; males had a higher rate of dyslipidemia than females (88.8% vs. 60.4%; p < 0.001). The most common type of disorder was increased LDL-C (57.9%), followed by increased total cholesterol (53.9%), increased triglycerides (42.1%), and decreased HDL-C (34.4%). The prevalence of hyperuricemia was 32.0%; the rate of hyperuricemia of males (41.7%) was higher than that of females (16.4%); p < 0.001. Dyslipidemia increased with age in both sexes (p < 0.001). Hyperuricemia was closely related to dyslipidemia and each individual lipid index (p < 0.001). Conclusion: The prevalences of dyslipidemia and hyperuricemia are high among individuals undergoing regular health check-ups, especially in males and the elderly. There is a significant correlation between these two disorders, requiring simultaneous screening and early intervention.

Article Details

References

1. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1):111-188.
2. Soltani Z, K Rasheed, DR Kapusta, and E Reisin. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: Is it time for reappraisal? Curr Hypertens Rep. 2013; 15(3):175-181.
3. Deji-Oloruntoba OO, JO Balogun, TO Elufioye, and SO Ajakwe, Hyperuricemia and insulin resistance: Interplay and potential for targeted therapies. International Journal of Translational Medicine. 2025; 5(3):30.
4. Du L, et al. Hyperuricemia and its related diseases: Mechanisms and advances in therapy. Signal Transduction and Targeted Therapy. 2024; 9(1):212.
5. Pham D, et al. Prevalence of dyslipidemia and associated factors among adults in rural Vietnam. Systematic Reviews in Pharmacy. 2020; 11:185-191.
6. Nguyen BT, TV Nguyen, TAD Le, and NT Le. Gender differences in risk factors for dyslipidemia in the Khmer ethnic people, Vietnam. Iran J Public Health. 2022; 51(11):2484-2493.
7. Nguyễn Thị Bích Ngọc, Nguyễn Thị Thủy, Nguyễn Như Vinh, Phạm Lê An. Tỉ lệ tăng acid uric máu, tỉ lệ bệnh gout và các yếu tố liên quan ở người trưởng thành đến phòng khám y học gia đình, Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh. Tạp chí Y học Việt Nam. 2023; 531(2).
8. Nguyễn Hải Long, Đoàn Văn Quyền, Huỳnh Văn Tính. Nghiên cứu tình hình và một số yếu tố liên quan đến tăng acid uric máu ở bệnh nhân đái tháo đường týp 2 tại Bệnh viện Đa khoa Kiên Giang năm 2021-2022. Tạp chí Y Dược học Cần Thơ. 2022; 52:185-190.
9. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25): 3143-3143.
10. Lee ZV, et al. Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region. Lipids Health Dis. 2021; 20(1):33.